Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Leading Skin Experts Back Free new CPD - 'Scratching The Surface' - to Upskill Primary Care Practitioners in Dermatology


News provided by

LEO Pharma UK

26 Nov, 2012, 08:00 GMT

Share this article

Share toX

Share this article

Share toX

PRINCES RISBOROUGH, England, November 26, 2012 /PRNewswire/ --

New online resource launched today for sun induced skin lesions management

With up to 25% of consultations in Primary Care being skin related, dermatology represents a large part of the working life of most healthcare professionals.[1] To help keep skills fresh and provide educational support where needed, skin experts have partnered with LEO Pharma, a leading specialist dermatology company to develop a new online CPD resource, 'Scratching the Surface' (STS). Launched today, with a focus on sun induced skin lesions, the resource is provides tailored Continuing Professional Development for GPs; pharmacists and nurses linked to their respective national colleges.

     (Logo: http://www.newscom.com/cgi-bin/prnh/20110606/460992 )

Highlighting the need for initiatives such as STS that provide education in dermatology, Charlotte Fionda, Development Director, Skcin, the UK's only national skin cancer specific charity commented, "With over a third of all cancers in the UK being skin cancers there is a real need for GPs to be upskilled in lesion recognition and to take early action to prevent the development of the disease."

"With increasing pressure on resources and the challenges faced by service redesign and commissioning, optimal referral management in dermatology is crucial. By supporting lesion recognition and management, STS may help to guide more appropriate referrals," added Consultant Dermatologist Dr Jonathan Bowling, Oxford.

Adrian Heagerty, Consultant Dermatologist, Solihull, who was a founding member of the project team commented, "We wanted to make STS an innovative practical tool that really encompasses holistic management and offers practical day to day advice using different media, including videos interactive elements, and of course lots of pictures which are key in dermatology education. The Visual Glossary, for example, is a really useful feature that can be left open on the users' desk top to refer to."

"Another innovation in STS is the use of images and commentary that show how sun induced skin lesions appear through a dermatoscope which can only help increase knowledge and understanding" added Dr Bowling.

After wide consultation STS has been structured to support interactive learning. "Continuing Professional Development (CPD) is central to STS; each section has clear learning objectives; reflection and personal action planning for improving patient care are included as separate CPD routes for doctors, nurses and pharmacists," commented Julie Van Onselen, Dermatology Nurse Specialist a key member the team who developed the resource.

Geraldine Murphy, Managing Director, LEO Pharma added, "At LEO we are passionate about education in dermatology so we are delighted to have developed the 'Scratching the Surface' (STS) online CPD resource. Our mission as an organisation is to help people achieve healthy skin and I am confident that STS will help achieve that goal."

Access to STS is free and the web based resource is mobile enabled so may be viewed on desktop as well as mobile devices such as tablets, iPad and iPhone. To register online go to http://www.learnwithscratchingthesurface.com

STS also features a module on psoriasis management from LEO Dermatology.

Notes for editors

About Scratching The Surface

Free to register for healthcare professionals, STS can help to optimise the way dermatology patients are managed. Most patients could be treated in primary care so a primary care team approach is essential to provide optimal care for patients and their families.

STS provides concise training and consultation tools, focused on practical and effective management.

Key features of STS include:

  • A visual glossary to help rapidly establish a differential diagnosis
  • Video case studies showing how all members of the healthcare team can contribute to optimal management
  • Knowledge tests to help increase confidence in identifying/managing skin conditions
  • An automatic tracker that records learning undertaken  to support each users' CPD portfolio

STS is designed to:

  • Enhance knowledge of key dermatological conditions linked to clear learning outcomes
  • Provide greater confidence for those caring for dermatology patients
  • Support more rewarding consultations with patients
  • Provide a stimulating way to enhance CPD

About LEO Pharma UK

LEO Pharma is a leading global pharmaceutical company specialising in dermatology (skin) and thromboembolic (blood clotting) care. Headquartered in Denmark, the Company has more than 5,000 employees in 61 countries and its products are sold in more than 100 countries.

LEO Pharma and its affiliates are independently owned by the LEO Foundation. This independent, private institution provides stability to plan and implement focused, long-term research and development programmes. It also allows LEO Pharma to make fast decisions, and respond quickly to great ideas. Thanks to the LEO Foundation, LEO Pharma is able to offer a long-term commitment to people with life-changing conditions, their healthcare professionals and associated patient support organisations.

LEO Pharma UK was established in 1960. Based in Princes Risborough, Buckinghamshire, the company employs approximately 240 people in Commercial, Sales, Marketing, Medical, Clinical Operations, Biometrics and Business Support Services. In the UK, LEO Pharma markets prescription only medicines with a focus on treating skin conditions such as psoriasis and infected eczema, as well as blood clots.

For more information visit: http://www.leo-pharma.co.uk

Reference

(1) Schofield J et al. Skin conditions in the UK - A healthcare needs assessment (2009). Available from http://www.nottingham.ac.uk/scs/documentsdivisions/documents/dermatology/hcnaskinconditions2009.pdf

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.